1. Case definition and phenotype standardization in drug-induced liver injury;Aithal;Clinical Pharmacology and Therapeutics,2011
2. Adverse drug reactions: a review of relevant factors;Ajayi;Journal of Clinical Pharmacology,2000
3. Pharmacogenetic testing: time for clinical practice guidelines;Amstutz;Clinical Pharmacology and Therapeutics,2011
4. Bayer Health Care Pharmaceuticals Inc. Betaseron (Interferon Beta-1b) for SC Injection Drug Monograph; 2011. Retrieved January 10, 2012 from 〈http://www.bayer.ca/files/BETASERON-PM-ENG-13JUL2011-133528.pdf〉
5. Biogen Idec. Avonex (Interferon-beta-1a) IM injection drug monograph; 2012a. Retrieved March 15, 2012 from 〈http://www.avonex.com/pdfs/guides/Avonex_Prescribing_Information.pdf〉.